A team from the University of Houston and MD Anderson Cancer Center is working to find early markers for ovarian cancer. Backed by a $1.2 million Department of Defense grant, a team led by Tianfu Wu, associate professor of biomedical engineering at UH, is studying autoantibodies that target a tumor suppressor gene that's often mutated in cancers and serves as an early marker of ovarian cancer development. According to UH, the majority of women with ovarian cancer (70 percent and 75 percent) a...| InnovationMap
Tens of thousands of Americans have relied on MD Anderson in Houston to care for their loved one, especially when a cancer diagnosis is made. MD Anderson is one of the most globally respected cancer centers in the world, employing more than 25,000 people, including more than 1,900 faculty, at a sprawling complex of more […]| The Hayride
Houston’s University of Texas MD Anderson Cancer Center has retained its U.S. News & World Report crown as the best cancer hospital in the U.S.| InnovationMap
“Every now and again, it is a good idea to open the door of the clown car that is MD Anderson, and see who climbs out. Today is the turn of Kapil N. Bhalla. If you say his name quickly, it so…| For Better Science
